Browse by UCL people
Group by: Type | Date
Number of items: 77.
Article
Ali, A;
Ambler, G;
Strydom, A;
Rai, D;
Cooper, C;
McManus, S;
Weich, S;
... Hassiotis, A; + view all
(2013)
The relationship between happiness and intelligent quotient: the contribution of socio-economic and clinical factors.
Psychological Medicine
, 43
(6)
pp. 1303-1312.
10.1017/S0033291712002139.
|
Ali, A;
Scior, K;
Ratti, V;
Strydom, A;
King, M;
Hassiotis, A;
(2013)
Discrimination and other barriers to accessing health care: perspectives of patients with mild and moderate intellectual disability and their carers.
PLoS One
, 8
(8)
, Article e70855. 10.1371/journal.pone.0070855.
|
Alić, I;
Goh, PA;
Murray, A;
Portelius, E;
Gkanatsiou, E;
Gough, G;
Mok, KY;
... Nižetić, D; + view all
(2020)
Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain.
Molecular Psychiatry
10.1038/s41380-020-0806-5.
|
Ashton, NJ;
Janelidze, S;
Al Khleifat, A;
Leuzy, A;
van der Ende, EL;
Karikari, TK;
Benedet, AL;
... Hansson, O; + view all
(2021)
A multicentre validation study of the diagnostic value of plasma neurofilament light.
Nature Communications
, 12
(1)
, Article 3400. 10.1038/s41467-021-23620-z.
|
Babulal, GM;
Quiroz, YT;
Albensi, BC;
Arenaza-Urquijo, E;
Astell, AJ;
Babiloni, C;
Bahar-Fuchs, A;
... International Society to Advance Alzheimer's Research and Treatm, .; + view all
(2019)
Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need.
Alzheimer's and Dementia
, 15
(2)
pp. 292-312.
10.1016/j.jalz.2018.09.009.
|
Billen, A;
Madrigal, JA;
Scior, K;
Shaw, BE;
Strydom, A;
(2017)
Donation of peripheral blood stem cells to unrelated strangers: A thematic analysis.
PLoS ONE
, 12
(10)
, Article e0186438. 10.1371/journal.pone.0186438.
|
Billen, A;
Madrigal, JA;
Strydom, A;
Szydlo, RM;
Switzer, GE;
Shaw, BE;
(2015)
Predonation Health-Related Quality of Life Scores Predict Time to Recovery in Hematopoietic Stem Cell Donors.
Biology of Blood and Marrow Transplantation
, 21
(2)
pp. 350-356.
10.1016/j.bbmt.2014.10.028.
|
Bosco, A;
Paulauskaite, L;
Hall, I;
Crabtree, J;
Soni, S;
Biswas, A;
Cooper, V;
... Hassiotis, A; + view all
(2019)
Process evaluation of a randomised controlled trial of PBS-based staff training for challenging behaviour in adults with intellectual disability.
PLoS One
, 14
(8)
, Article e0221507. 10.1371/journal.pone.0221507.
|
Buss, L;
Fisher, E;
Hardy, J;
Nizetic, D;
Groet, J;
Pulford, L;
Strydom, A;
(2016)
Intracerebral haemorrhage in Down syndrome: protected or predisposed?
F1000Research
, 5
, Article 876. 10.12688/f1000research.7819.1.
|
Buszewicz, MJ;
Welch, C;
Horsfall, L;
Nazareth, I;
Osborn, D;
Hassiotis, A;
Glover, G;
... Strydom, A; + view all
(2014)
Assessment of an incentivised scheme to provide annual health checks in primary care for adults with intellectual disability: a longitudinal cohort study.
The Lancet Pyschiatry
, 1
(7)
pp. 522-530.
10.1016/S2215-0366(14)00079-0.
|
Dekker, AD;
Strydom, A;
Coppus, AM;
Nizetic, D;
Vermeiren, Y;
Naudé, PJ;
Van Dam, D;
... De Deyn, PP; + view all
(2015)
Behavioural and psychological symptoms of dementia in Down syndrome: Early indicators of clinical Alzheimer's disease?
Cortex
, 73
pp. 36-61.
10.1016/j.cortex.2015.07.032.
|
Dierssen, M;
Herault, Y;
Helguera, P;
Martinez de Lagran, M;
Vazquez, A;
Christian, B;
Carmona-Iragui, M;
... Bhattacharyya, A; + view all
(2021)
Building the Future Therapies for Down Syndrome: The Third International Conference of the T21 Research Society.
Molecular Syndromology
10.1159/000514437.
(In press).
|
Dodd, K;
Watchman, K;
Janicki, MP;
Coppus, A;
Gaertner, C;
Fortea, J;
Santos, FH;
... Strydom, A; + view all
(2018)
Consensus statement of the international summit on intellectual disability and Dementia related to post-diagnostic support.
Aging & Mental Health
, 22
(11)
pp. 1406-1415.
10.1080/13607863.2017.1373065.
|
Eady, N;
Courtenay, K;
Strydom, A;
(2015)
Pharmacological Management of Behavioral and Psychiatric Symptoms in Older Adults with Intellectual Disability.
Drugs & Aging
, 32
(2)
pp. 95-102.
10.1007/s40266-014-0236-7.
|
Eady, N;
Sheehan, R;
Rantell, K;
Sinai, A;
Bernal, J;
Bohnen, I;
Bonell, S;
... Strydom, A; + view all
(2018)
Impact of cholinesterase inhibitors or memantine on survival in adults with Down syndrome and dementia: clinical cohort study.
British Journal of Psychiatry
, 212
(3)
pp. 155-160.
10.1192/bjp.2017.21.
|
Emes, D;
Hüls, A;
Baumer, N;
Dierssen, M;
Puri, S;
Russell, L;
Sherman, SL;
... Lakhanpaul, M; + view all
(2021)
Covid-19 in children with down syndrome: Data from the trisomy 21 research society survey.
Journal of Clinical Medicine
, 10
(21)
, Article 5125. 10.3390/jcm10215125.
|
Faundez, V;
De Toma, I;
Bardoni, B;
Bartesaghi, R;
Nizetic, D;
de la Torre, R;
Cohen Kadosh, R;
... Strydom, A; + view all
(2018)
Translating molecular advances in Down syndrome and Fragile X syndrome into therapies.
European Neuropsychopharmacology
, 28
(6)
pp. 675-690.
10.1016/j.euroneuro.2018.03.006.
|
Firth, NC;
Startin, CM;
Hithersay, R;
Hamburg, S;
Wijeratne, PA;
Mok, KY;
Hardy, J;
... Strydom, A; + view all
(2018)
Aging related cognitive changes associated with Alzheimer's disease in Down syndrome.
Annals of Clinical and Translational Neurology
, 5
(6)
pp. 741-751.
10.1002/acn3.571.
|
Fletcher, RJ;
Barnhill, J;
McCarthy, J;
Strydom, A;
(2016)
From DSM to DM-ID.
Journal of Mental Health Research in Intellectual Disabilities
, 9
(3)
pp. 189-204.
10.1080/19315864.2016.1185324.
|
Hamburg, S;
Rosch, R;
Startin, CM;
Friston, KJ;
Strydom, A;
(2019)
Dynamic Causal Modeling of the Relationship between Cognition and Theta-alpha Oscillations in Adults with Down Syndrome.
Cerebral Cortex
10.1093/cercor/bhz043.
(In press).
|
Hamburg, S;
Startin, CM;
Strydom, A;
(2017)
The Relationship Between Sound–Shape Matching and Cognitive Ability in Adults With Down Syndrome.
Multisensory Research
, 30
(6)
pp. 537-547.
10.1163/22134808-00002579.
|
Hassiotis, A;
Strydom, A;
Crawford, M;
Hall, I;
Omar, R;
Vickerstaff, V;
Hunter, R;
... King, M; + view all
(2014)
Clinical and cost effectiveness of staff training in Positive Behaviour Support (PBS) for treating challenging behaviour in adults with intellectual disability: a cluster randomised controlled trial.
BMC PSYCHIATRY
, 14
(ARTN 219)
10.1186/s12888-014-0219-6.
|
Hassiotis, A;
Gazizova, D;
Akinlonu, L;
Bebbington, P;
Meltzer, H;
Strydom, A;
(2011)
Psychiatric morbidity in prisoners with intellectual disabilities: analysis of prison survey data for England and Wales.
British Journal of Psychiatry
, 199
(2)
pp. 156-157.
10.1192/bjp.bp.110.088039.
|
Hassiotis, A;
Poppe, M;
Strydom, A;
Vickerstaff, V;
Hall, I;
Crabtree, J;
Omar, R;
... Crawford, M; + view all
(2018)
Positive behaviour support training for staff for treating challenging behaviour in people with intellectual disabilities: a cluster RCT.
Health Technology Assessment
, 22
(15)
pp. 1-110.
10.3310/hta22150.
|
Hassiotis, A;
Poppe, M;
Strydom, A;
Vickerstaff, V;
Hall, IS;
Crabtree, J;
Omar, RZ;
... Crawford, MJ; + view all
(2018)
Clinical outcomes of staff training in positive behaviour support to reduce challenging behaviour in adults with intellectual disability: cluster randomised controlled trial.
The British Journal of Psychiatry
, 212
(3)
pp. 161-168.
|
Hassiotis, A;
Serfaty, M;
Azam, K;
Strydom, A;
Martin, S;
Parkes, C;
Blizard, R;
(2011)
Cognitive behaviour therapy (CBT) for anxiety and depression in adults with mild intellectual disabilities (ID): a pilot randomised controlled trial.
Trials
, 12
, Article 95. 10.1186/1745-6215-12-95.
|
Hithersay, R;
Baksh, RA;
Startin, CM;
Wijeratne, P;
Hamburg, S;
Carter, B;
LonDownS Consortium;
(2020)
Optimal age and outcome measures for Alzheimer's disease prevention trials in people with Down syndrome.
Alzheimer's & Dementia
10.1002/alz.12222.
(In press).
|
Hithersay, R;
Hamburg, S;
Knight, B;
Strydom, A;
(2017)
Cognitive decline and dementia in Down syndrome.
Current Opinion in Psychiatry
, 30
(2)
pp. 102-107.
10.1097/YCO.0000000000000307.
|
Hithersay, R;
Startin, CM;
Hamburg, S;
Mok, KY;
Hardy, J;
Fisher, EMC;
Tybulewicz, VLJ;
... Strydom, A; + view all
(2019)
Association of Dementia With Mortality Among Adults With Down Syndrome Older Than 35 Years.
JAMA Neurology
, 76
(2)
pp. 152-160.
10.1001/jamaneurol.2018.3616.
|
Hithersay, R;
Strydom, A;
Moulster, G;
Buszewicz, M;
(2014)
Carer-led health interventions to monitor, promote and improve the health of adults with intellectual disabilities in the community: a systematic review.
Research in Developmental Disabilities
, 35
(4)
pp. 887-907.
10.1016/j.ridd.2014.01.010.
|
Hüls, A;
Costa, ACS;
Dierssen, M;
Baksh, RA;
Bargagna, S;
Baumer, NT;
Brandão, AC;
... T21RS COVID-19 Initiative; + view all
(2021)
Medical vulnerability of individuals with Down syndrome to severe COVID-19–data from the Trisomy 21 Research Society and the UK ISARIC4C survey.
EClinicalMedicine
, Article 100769. 10.1016/j.eclinm.2021.100769.
(In press).
|
Hunter, RM;
Vickerstaff, V;
Poppe, M;
Strydom, A;
King, M;
Hall, I;
Crabtree, J;
... Hassiotis, A; + view all
(2020)
Staff training in positive behaviour support for behaviour that challenges in people with intellectual disability: cost-utility analysis of a cluster randomised controlled trial.
BJPsych Open
, 6
(2)
, Article e15. 10.1192/bjo.2020.1.
|
Karmiloff-Smith, A;
Al-Janabi, T;
D'Souza, H;
Groet, J;
Massand, E;
Mok, K;
Startin, C;
... Strydom, A; + view all
(2016)
The importance of understanding individual differences in Down syndrome.
F1000Research
, 5
, Article 389. 10.12688/f1000research.7506.1.
|
Mandy, W;
Clarke, K;
McKenner, M;
Strydom, A;
Crabtree, J;
Lai, M-C;
Allison, C;
... Skuse, D; + view all
(2017)
Assessing Autism in Adults: An Evaluation of the Developmental, Dimensional and Diagnostic Interview-Adult Version (3Di-Adult).
Journal of Autism and Developmental Disorders
10.1007/s10803-017-3321-z.
(In press).
|
Montoliu-Gaya, L;
Strydom, A;
Blennow, K;
Zetterberg, H;
Ashton, NJ;
(2021)
Blood Biomarkers for Alzheimer's Disease in Down Syndrome.
Journal of Clinical Medicine
, 10
(16)
, Article 3639. 10.3390/jcm10163639.
|
Panca, M;
Buszewicz, M;
Strydom, A;
Hassiotis, A;
Welch, CA;
Hunter, RM;
(2019)
Resource use and cost of annual health checks in primary care for people with intellectual disabilities.
Journal of Intellectual Disability Research
, 63
(3)
pp. 233-243.
10.1111/jir.12569.
|
Sheehan, R;
Hassiotis, A;
Strydom, A;
Morant, N;
(2019)
Experiences of psychotropic medication use and decision-making for adults with intellectual disability: a multistakeholder qualitative study in the UK.
BMJ Open
, 9
(11)
, Article e032861. 10.1136/bmjopen-2019-032861.
|
Sheehan, R;
Hassiotis, A;
Walters, K;
Osborn, D;
Strydom, A;
Horsfall, L;
(2015)
Mental illness, challenging behaviour, and psychotropic drug prescribing in people with intellectual disability: UK population based cohort study.
BMJ
, 351
, Article h4326. 10.1136/bmj.h4326.
|
Sheehan, R;
Horsfall, L;
Strydom, A;
Osborn, D;
Walters, K;
Hassiotis, A;
(2017)
Movement side effects of antipsychotic drugs in adults with and without intellectual disability: UK population-based cohort study.
BMJ Open
, 7
(8)
, Article e017406. 10.1136/bmjopen-2017-017406.
|
Sheehan, R;
Sinai, A;
Bass, N;
Blatchford, P;
Bohnen, I;
Bonell, S;
Courtenay, K;
... Strydom, A; + view all
(2015)
Dementia diagnostic criteria in Down syndrome.
International Journal of Geriatric Psychiatry
, 30
(8)
pp. 857-863.
10.1002/gps.4228.
|
Sheehan, R;
Strydom, A;
Brown, E;
Marston, L;
Hassiotis, A;
(2018)
Association of Focused Medication Review With Optimization of Psychotropic Drug Prescribing.
JAMA Network Open
, 1
(6)
, Article e183750. 10.1001/jamanetworkopen.2018.3750.
|
Sheehan, R;
Strydom, A;
Marston, L;
Morant, N;
Fiori, F;
Santosh, P;
Hassiotis, A;
(2019)
A structured medication review tool to promote psychotropic medication optimisation for adults with intellectual disability: feasibility study.
BMJ Open
, 9
(12)
, Article e033827. 10.1136/bmjopen-2019-033827.
|
Sheehan, R;
Strydom, A;
Morant, N;
Pappa, E;
Hassiotis, A;
(2017)
Psychotropic prescribing in people with intellectual disability and challenging behaviour.
[Editorial comment].
BMJ
, 358
, Article j3896. 10.1136/bmj.j3896.
|
Sinai, A;
Bohnen, I;
Strydom, A;
(2012)
Older adults with intellectual disability.
Current Opinion in Psychiatry
, 25
(5)
pp. 359-364.
10.1097/YCO.0b013e328355ab26.
|
Sinai, A;
Hassiotis, A;
Rantell, K;
Strydom, A;
(2016)
Assessing Specific Cognitive Deficits Associated with Dementia in Older Adults with Down Syndrome: Use and Validity of the Arizona Cognitive Test Battery (ACTB).
PLoS One
, 11
(5)
, Article e0153917. 10.1371/journal.pone.0153917.
|
Sinai, A;
Mokrysz, C;
Bernal, J;
Bohnen, I;
Bonell, S;
Courtenay, K;
Dodd, K;
... Strydom, A; + view all
(2017)
Predictors of Age of Diagnosis and Survival of Alzheimer's Disease in Down Syndrome.
Journal of Alzheimer's Disease
, 61
(2)
pp. 717-728.
10.3233/JAD-170624.
|
Startin, CM;
Hamburg, S;
Hithersay, R;
Al-Janabi, T;
Mok, KY;
Hardy, J;
LonDownS Consortium, .;
(2019)
Cognitive markers of preclinical and prodromal Alzheimer's disease in Down syndrome.
Alzheimer's & Dementia
, 15
(2)
pp. 245-257.
10.1016/j.jalz.2018.08.009.
|
Startin, CM;
Ashton, NJ;
Hamburg, S;
Hithersay, R;
Wiseman, FK;
Mok, KY;
Hardy, J;
... Strydom, A; + view all
(2019)
Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer's disease.
Alzheimer's Research & Therapy
, 11
, Article 26. 10.1186/s13195-019-0477-0.
|
Startin, CM;
D'Souza, H;
Ball, G;
Hamburg, S;
Hithersay, R;
Hughes, KMO;
Massand, E;
... Strydom, A; + view all
(2020)
Health comorbidities and cognitive abilities across the lifespan in Down syndrome.
Journal of Neurodevelopmental Disorders
, 12
, Article 4. 10.1186/s11689-019-9306-9.
|
Startin, CM;
Hamburg, S;
Hithersay, R;
Davies, A;
Rodger, E;
Aggarwal, N;
Al-Janabi, T;
(2016)
The LonDownS adult cognitive assessment to study cognitive abilities and decline in Down syndrome [version 1; referees: awaiting peer review].
Wellcome Open Research
, 1
(11)
10.12688/wellcomeopenres.9961.1.
|
Startin, CM;
Hamburg, S;
Strydom, A;
Strydom, A;
Fisher, E;
Nizetic, D;
Hardy, J;
... Karmiloff-Smith, A; + view all
(2019)
Comparison of Receptive Verbal Abilities Assessed Using the KBIT-2 and BPVS3 in Adults With Down Syndrome.
Frontiers in Psychology
, 9
, Article 2730. 10.3389/fpsyg.2018.02730.
|
Startin, CM;
Lowe, B;
Hamburg, S;
Hithersay, R;
Strydom, A;
Fisher, E;
Nizetic, D;
... Karmiloff-Smith, A; + view all
(2019)
Validating the Cognitive Scale for Down Syndrome (CS-DS) to Detect Longitudinal Cognitive Decline in Adults With Down Syndrome.
Frontiers in Psychiatry
, 10
, Article 158. 10.3389/fpsyt.2019.00158.
|
Startin, CM;
Rodger, E;
Fodor-Wynne, L;
Hamburg, S;
Strydom, A;
(2016)
Developing an Informant Questionnaire for Cognitive Abilities in Down Syndrome: The Cognitive Scale for Down Syndrome (CS-DS).
PLoS One
, 11
(5)
, Article e0154596. 10.1371/journal.pone.0154596.
|
Strydom, Andre;
Giaroli, Giovanni;
Bass, Nicholas;
Rantell, Khadijia;
McQuillin, Andrew;
(2014)
Does rare matter? Copy Number Variants at 16p11.2 and the risk of psychosis: A systematic review of literature and metaanalysis.
Schizophrenia Research
, 159
(2-3)
pp. 340-346.
10.1016/j.schres.2014.09.025.
|
Strydom, A;
Bosco, A;
Vickerstaff, V;
Hunter, R;
PBS study group;
Hassiotis, A;
(2020)
Clinical and cost effectiveness of staff training in the delivery of Positive Behaviour Support (PBS) for adults with intellectual disabilities, autism spectrum disorder and challenging behaviour - randomised trial.
BMC Psychiatry
, 20
, Article 161. 10.1186/s12888-020-02577-1.
|
Strydom, A;
Chan, T;
Fenton, C;
Jamieson-Craig, R;
Livingston, G;
Hassiotis, A;
(2013)
Validity of Criteria for Dementia in Older People With Intellectual Disability.
The American Journal of Geriatric Psychiatry
, 21
(3)
pp. 279-288.
10.1016/j.jagp.2012.11.017.
|
Strydom, A;
Chan, T;
King, M;
Hassiotis, A;
Livingston, G;
(2013)
Incidence of dementia in older adults with intellectual disabilities.
Research in Developmental Disabilities
, 34
(6)
pp. 1881-1885.
10.1016/j.ridd.2013.02.021.
|
Strydom, A;
Coppus, A;
Blesa, R;
Danek, A;
Fortea, J;
Hardy, J;
Levin, J;
... Zetterberg, H; + view all
(2018)
Alzheimer's disease in Down syndrome: An overlooked population for prevention trials.
Alzheimer's and Dementia: Translational Research and Clinical Interventions
, 4
pp. 703-713.
10.1016/j.trci.2018.10.006.
|
Strydom, A;
Heslegrave, A;
Startin, CM;
Mok, KY;
Hardy, J;
Groet, J;
Nizetic, D;
... LonDownS Consortium; + view all
(2018)
Neurofilament light as a blood biomarker for neurodegeneration in Down syndrome.
Alzheimer's Research & Therapy
, 10
(1)
, Article 39. 10.1186/s13195-018-0367-x.
|
Strydom, A;
Melville, C;
(2017)
New horizons for mental health research in intellectual disabilities.
[Editorial comment].
Journal of Intellectual Disability Research
, 61
(6)
pp. 519-520.
10.1111/jir.12383.
|
Strydom, A;
Romeo, R;
Perez-Achiaga, N;
Livingston, G;
King, M;
Knapp, M;
Hassiotis, A;
(2010)
Service use and cost of mental disorder in older adults with intellectual disability.
British Journal of Psychiatry
, 196
(2)
133 - 138.
10.1192/bjp.bp.108.060939.
|
Strydom, A;
Shooshtari, S;
Lee, L;
Raykar, V;
Torr, J;
Tsiouris, J;
Jokinen, N;
... Maaskant, M; + view all
(2010)
Dementia in Older Adults With Intellectual Disabilities—Epidemiology, Presentation, and Diagnosis.
Journal of Policy and Practice in Intellectual Disabilities
, 7
(2)
96 - 110.
10.1111/j.1741-1130.2010.00253.x.
|
Strydom, A.;
Hassiotis, A.;
King, M.;
Livingston, G.;
(2009)
The relationship of dementia prevalence in older adults with intellectual disability (ID) to age and severity of ID.
Psychological Medicine
, 39
(01)
pp. 13-21.
10.1017/S0033291708003334.
|
Thomas, B;
Courtenay, K;
Hassiotis, A;
Strydom, A;
Rantell, K;
(2014)
Standardised patients with intellectual disabilities in training tomorrow's doctors.
Psychiatric Bulletin
, 38
(3)
pp. 132-136.
10.1192/pb.bp.113.043547.
|
Thygesen, JH;
Wolfe, K;
McQuillin, A;
Viñas-Jornet, M;
Baena, N;
Brison, N;
D'Haenens, G;
... Vogels, A; + view all
(2018)
Neurodevelopmental risk copy number variants in adults with intellectual disabilities and comorbid psychiatric disorders.
The British Journal of Psychiatry
, 212
(5)
pp. 287-294.
10.1192/bjp.2017.65.
|
Tosh, JL;
Rhymes, ER;
Mumford, P;
Whittaker, HT;
Pulford, LJ;
Noy, SJ;
Cleverley, K;
... Wiseman, FK; + view all
(2021)
Genetic dissection of down syndrome-associated alterations in APP/amyloid-β biology using mouse models.
Scientific Reports
, 11
(1)
, Article 5736. 10.1038/s41598-021-85062-3.
|
Wiseman, FK;
Al-Janabi, T;
Hardy, J;
Karmiloff-Smith, A;
Nizetic, D;
Tybulewicz, VLJ;
Fisher, EMC;
(2015)
A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome.
Nature Reviews Neuroscience
, 16
(9)
pp. 564-574.
10.1038/nrn3983.
|
Wiseman, FK;
Pulford, LJ;
Barkus, C;
Liao, F;
Portelius, E;
Webb, R;
Chávez-Gutiérrez, L;
... Fisher, EMC; + view all
(2018)
Trisomy of human chromosome 21 enhances amyloid-β deposition independently of an extra copy of APP.
Brain
, 141
(8)
pp. 2457-2474.
10.1093/brain/awy159.
|
Wolfe, K;
McQuillin, A;
Alesi, V;
Boudry Labis, E;
Cutajar, P;
Dallapiccola, B;
Dentici, ML;
... Bass, N; + view all
(2018)
Delineating the psychiatric and behavioral phenotype of recurrent 2q13 deletions and duplications.
American Journal of Medical Genetics: Part B Neuropsychiatric Genetics
, 177
(4)
pp. 397-405.
10.1002/ajmg.b.32627.
|
Wolfe, K;
Strydom, A;
Morrogh, D;
Carter, J;
Cutajar, P;
Eyeoyibo, M;
Hassiotis, A;
... Bass, N; + view all
(2016)
Chromosomal microarray testing in adults with intellectual disability presenting with comorbid psychiatric disorders.
European Journal of Human Genetics
, 25
(1)
pp. 66-72.
10.1038/ejhg.2016.107.
|
Wolfe, K;
Stueber, K;
McQuillin, A;
Jichi, F;
Patch, C;
Flinter, F;
Strydom, A;
(2017)
Genetic testing in intellectual disability psychiatry: Opinions and practices of UK child and intellectual disability psychiatrists.
J Appl Res Intellect Disabil
10.1111/jar.12391.
(In press).
|
Zis, P;
Dickinson, M;
Shende, S;
Walker, Z;
Strydom, A;
(2012)
Oxidative Stress and Memory Decline in Adults with Down Syndrome: Longitudinal Study.
Journal of Alzheimer's Disease
, 31
(2)
pp. 277-283.
10.3233/JAD-2012-120073.
|
Zis, P;
McHugh, P;
McQuillin, A;
Praticò, D;
Dickinson, M;
Shende, S;
Walker, Z;
(2014)
Memory Decline in Down Syndrome and Its Relationship to iPF2alpha, a Urinary Marker of Oxidative Stress.
PLoS One
, 9
(6)
, Article e97709. 10.1371/journal.pone.0097709.
|
Zis, P;
Strydom, A;
(2018)
Clinical aspects and biomarkers of Alzheimer's disease in Down syndrome.
Free Radical Biology and Medicine
, 114
pp. 3-9.
10.1016/j.freeradbiomed.2017.08.024.
|
Zis, P;
Strydom, A;
Buckley, D;
Adekitan, D;
McHugh, PC;
(2017)
Cognitive ability in Down syndrome and its relationship to urinary neopterin, a marker of activated cellular immunity.
Neuroscience Letters
, 636
pp. 254-257.
10.1016/j.neulet.2016.11.023.
|
Book chapter
Bebbington, PE;
Rai, D;
Strydom, A;
Brugha, T;
McManus, S;
Morgan, Z;
(2016)
Chapter 5: Psychotic disorder.
In: McManus, S and Bebbington, P and Jenkins, R and Brugha, T, (eds.)
Adult Psychiatric Morbidity Survey: Survey of Mental Health and Wellbeing, England, 2014.
(pp. 132-152).
Health and Social Care Information Centre
|
Thesis
Billen, A;
(2015)
The impact of donor health and psychosocial factors on the donation experience and recovery.
Doctoral thesis , UCL (University College London).
|